Clomipramine hydrochloride
Company: Mylan LaboratoriesApproval Status: Approved April 1998
Treatment for: depression
Areas: Diabetes / Endocrinology; Psychiatry / Psychiatric
General Information
Clomipramine hydrochloride capsules, the generic equivalent of Novartis' Anafranil, have been approved. The drug will be manufactured in 25 mg, 50 mg, and 75 mg strengths.
Clomipramine hydrochloride Drug Information
The Clomipramine Hydrochloride drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
